PRESS RELEASE published on 07/28/2025 at 14:30, 1 year 3 months ago Eckert & Ziegler: Capital Increase Entered in the Commercial Register. Share Split in Preparation. Eckert & Ziegler SE increases capital and prepares for share split, aiming to enhance share liquidity and trading. Leading in isotope-related components for nuclear medicine and radiation therapy Liquidity Eckert & Ziegler Capital Increase Share Split Isotope-related Components
BRIEF published on 07/15/2025 at 14:05, 1 year 3 months ago Eckert & Ziegler's Training Program Recognized for Excellence Training Excellence Berlin Chamber Award Trainee Retention Career Prospects Future Applications
PRESS RELEASE published on 07/15/2025 at 14:00, 1 year 3 months ago Eckert & Ziegler: Outstanding Training Quality Once Again Awarded Eckert & Ziegler SE awarded for exceptional training quality by Berlin Chamber of Industry and Commerce for the fourth consecutive time, emphasizing practical experience and career prospects for trainees Eckert & Ziegler Career Prospects Training Quality Berlin Chamber Of Industry And Commerce Trainee Team
BRIEF published on 06/18/2025 at 16:10, 1 year 4 months ago Eckert & Ziegler SE Declares EUR 0.50 Dividend at Annual General Meeting Annual General Meeting Shareholders Dividend Financial Year 2024 Eckert & Ziegler SE
PRESS RELEASE published on 06/18/2025 at 16:05, 1 year 4 months ago Annual General Meeting of Eckert & Ziegler SE Approves Dividend of EUR 0.50 Eckert & Ziegler SE's Annual General Meeting approves dividend of EUR 0.50 per share for 2024 fiscal year. Detailed voting results available online Annual General Meeting Shareholders Voting Results Dividend Eckert & Ziegler SE
BRIEF published on 06/05/2025 at 10:05, 1 year 4 months ago Eckert & Ziegler Expands with Approval of Illuccix® in Germany Gallium-68 Nuclear Medicine Prostate Cancer Illuccix® PSMA-PET Imaging
PRESS RELEASE published on 06/05/2025 at 10:00, 1 year 4 months ago Eckert & Ziegler: Illuccix® PSMA-PET Imaging Agent Receives Approval in Germany Eckert & Ziegler announces the approval of Illuccix® PSMA-PET Imaging Agent in Germany, expanding its nuclear medicine portfolio and partnership with Telix Pharmaceuticals Eckert & Ziegler Germany Approval Illuccix PSMA-PET
BRIEF published on 05/30/2025 at 10:05, 1 year 5 months ago Eckert & Ziegler Hosts Successful Boston Radionuclide Theranostics Forum Precision Oncology Industry Collaboration Radiopharmaceuticals Theranostics Forum Event Insights
PRESS RELEASE published on 05/30/2025 at 10:00, 1 year 5 months ago Eckert & Ziegler Organizes Third Boston Radionuclide Theranostics Forum Eckert & Ziegler successfully completes the 3rd annual Boston Radionuclide Theranostics Forum, gathering key leaders to discuss radionuclides in precision oncology Innovation Eckert & Ziegler Precision Oncology Radiopharmaceuticals Boston Radionuclide Theranostics Forum
BRIEF published on 05/23/2025 at 10:05, 1 year 5 months ago Eckert & Ziegler Receives Prestigious Management Award Again Eckert & Ziegler Nuclear Medicine Best Managed Companies Deloitte Private Isotopes
Published on 10/30/2026 at 23:35, 19 hours 13 minutes ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 19 hours 18 minutes ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 20:47, 22 hours 1 minute ago CoTec Holdings Corp. Comments on Share Trading
Published on 10/30/2026 at 19:00, 23 hours 48 minutes ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 1 day 3 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 10/31/2026 at 16:35, 2 hours 13 minutes ago SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 19 hours 59 minutes ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 18:38, 1 day ago EQS-Adhoc: Starcom Holding AD publishes Interim Q3 2026 Financial Report
Published on 10/30/2026 at 23:00, 19 hours 48 minutes ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 12:00, 1 day 6 hours ago Capital increase through exercise of subscription rights
